Inicio
kardia mobile 6l
KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News

KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News

4.7 (323) · € 71.50 · En stock

KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.

AliveCor scores QT prolongation clearance for its portable ECG to track dangerous drug side effects

ECG Archives - Cardiac Rhythm News

Latest News Archives - Cardiac Rhythm News

A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young

PDF) Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients

COVID-19 Archives - Cardiac Rhythm News

Delve Health and AliveCor team up on cardiac care

2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart

Manual QT interval measurement with a smartphone-operated single-lead ECG versus 12-lead ECG: a within-patient diagnostic validation study in primary care